-
Net income per diluted share, continuing operations, of
$0.56 , a significant increase over first quarter 2014 net income per diluted share, continuing operations, of$0.10 . -
Adjusted net income per diluted share, continuing operations,1
of
$0.71 , a significant increase over first quarter 2014 adjusted net income per diluted share, continuing operations,1 of$0.27 . -
Total revenue of
$3.2 billion , up 53% over first quarter 2014. - Aggregate membership up 38% over first quarter 2014.
-
Unreimbursed health insurer fees and
Texas quality revenue reduce income before taxes by approximately$23 million , or$0.29 per diluted share, in the first quarter of 2015.
"We are very pleased with our first quarter results, which represent a
down payment on the improved profitability we committed to at our
investor day this past February," said
Overview of Financial Results, Continuing Operations
Financial results for the first quarter of 2015 improved markedly over the first quarter of 2014 due to higher revenue, greater administrative cost efficiency, and steady medical care costs. Both income from continuing operations before income tax expense and net income per diluted share, continuing operations, were approximately six times greater in the first quarter of 2015 than in the first quarter of 2014.
Premium revenue increased approximately 53% in the first quarter of 2015 compared with the first quarter of 2014, resulting from:
- An increase of over 38% in enrollment due to growth across all health plan programs.
- An increase of nearly 15% in premium revenue per member per month (PMPM) due to membership growth in programs serving the needs of members with more complex medical conditions for whom the Company receives higher monthly premiums.
Medical care costs as a percent of premium revenue (the "medical care ratio") were consistent with the first quarter of 2014 at 88.7% and improved over the fourth quarter of 2014 medical care ratio of 89.4%. Medical margin (defined as the excess of premium revenue over medical care costs) increased 53% in 2015 over 2014.
General and administrative expenses as a percentage of total revenue
(the "general and administrative expense ratio") decreased significantly
to 8.1% in the first quarter of 2015 compared with 9.1% in the first
quarter of 2014. The decrease in the general and administrative expense
ratio would have been even greater but for expenses associated with the
start-up of the Company's
Health Insurer Fee Update
The Company's results continue to be adversely affected by delays in reimbursement of the Affordable Care Act's Health Insurer Fee (HIF) by some states.
Due to progress made in securing agreements for the reimbursement of the
HIF with various state
Delay in recognition of the HIF expense reimbursement from
The comparable amount of HIF reimbursement not recognized in the first
quarter of 2014 was approximately
During the first quarter of 2015, the Company did not recognized any of
the
Texas Health Plan Quality Revenue Update
The Company did not recognize approximately
The Company recognized no
Classification of 1.125% Cash Convertible Senior Notes
The Company's 1.125% Notes met the stock price trigger in the quarter
ended
Conference Call
The Company's management will host a conference call and webcast to
discuss its first quarter results at
About
Notes:
1. Adjusted net income per diluted share, continuing operations, is a
non-GAAP financial measure used by management as a supplemental metric
in evaluating its financial performance, its financing and business
decisions, and in forecasting and planning for future periods. This
measure is not determined in accordance with accounting principles
generally accepted in
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This earnings release contains “forward-looking statements” regarding the Company’s plans, expectations, and anticipated future events. Actual results could differ materially due to numerous known and unknown risks and uncertainties. Those known risks and uncertainties include, but are not limited to, the following:
-
continuing uncertainties associated with the implementation of the
Affordable Care Act, including the full grossed up reimbursement by
states of the non-deductible ACA health insurer fee, the
Medicaid expansion, the insurance marketplaces, the effect of various implementing regulations, the King v. Burwell case now pending before theSupreme Court , and uncertainties regarding the Medicare-Medicaid dual eligible demonstration programs inCalifornia ,Illinois ,Michigan ,Ohio ,South Carolina , andTexas ; - management of our medical costs, including seasonal flu patterns and rates of utilization that are consistent with our expectations, and our ability to reduce over time the high medical costs commonly associated with new patient populations;
- federal or state medical cost expenditure floors, administrative cost and profit ceilings, and profit sharing arrangements;
-
the interpretation and implementation of at-risk premium rules
regarding the achievement of certain quality measures, including 2014
and 2015 at-risk premium rules in the state of
Texas ; - cyber-attacks or other privacy or data security incidents resulting in an inadvertent unauthorized disclosure of protected health information;
-
the success of our new health plan in
Puerto Rico ; -
newly
FDA -approved specialty drugs such as Sovaldi, Olysio, Harvoni, and other specialty drugs or generic drugs that are exorbitantly priced but not factored into the calculation of our capitated rates; - significant budget pressures on state governments and their potential inability to maintain current rates, to implement expected rate increases, or to maintain existing benefit packages or membership eligibility thresholds or criteria;
- the accurate estimation of incurred but not paid medical costs across our health plans;
-
retroactive adjustments to premium revenue or accounting estimates
which require adjustment based upon subsequent developments, including
Medicaid pharmaceutical rebates or retroactive premium rate increases; - efforts by states to recoup previously paid amounts;
- the success of our efforts to retain existing government contracts and to obtain new government contracts in connection with state requests for proposals (RFPs) in both existing and new states;
- the continuation and renewal of the government contracts of both our health plans and Molina Medicaid Solutions and the terms under which such contracts are renewed;
-
complications, member confusion, or enrollment backlogs related to
the annual renewal of
Medicaid coverage; - government audits and reviews, and any fine, enrollment freeze, or monitoring program that may result therefrom;
- changes with respect to our provider contracts and the loss of providers;
- approval by state regulators of dividends and distributions by our health plan subsidiaries;
- changes in funding under our contracts as a result of regulatory changes, programmatic adjustments, or other reforms;
- high dollar claims related to catastrophic illness;
-
the favorable or unfavorable resolution of litigation, arbitration,
or administrative proceedings, including pending qui tam actions in
Florida andCalifornia , and the litigation commenced against us by the state ofLouisiana alleging that Molina Medicaid Solutions and its predecessors used an incorrect reimbursement formula for the payment of pharmaceutical claims; - the relatively small number of states in which we operate health plans;
-
our management of a portion of College Health Enterprises’ hospital
in
Long Beach, California ; - the availability of adequate financing on acceptable terms to fund and capitalize our expansion and growth, repay our outstanding indebtedness at maturity and meet our liquidity needs, including the interest expense and other costs associated with such financing;
-
the failure of a state in which we operate to renew its federal
Medicaid waiver; -
changes generally affecting the managed care or
Medicaid management information systems industries; - increases in government surcharges, taxes, and assessments;
- public alarm associated with the Ebola virus, measles, or any actual widespread epidemic;
- changes in general economic conditions, including unemployment rates;
-
increasing competition and consolidation in the
Medicaid industry;
and numerous other risk factors, including those discussed in the
Company's periodic reports and filings with the
MOLINA HEALTHCARE, INC. UNAUDITED CONSOLIDATED STATEMENTS OF INCOME |
||||||||||
Three Months Ended March 31, |
||||||||||
2015 | 2014 | |||||||||
(Amounts in thousands, except |
||||||||||
Revenue: | ||||||||||
Premium revenue | $ | 2,970,652 | $ | 1,940,337 | ||||||
Service revenue | 51,858 | 53,630 | ||||||||
Premium tax revenue | 95,347 | 51,693 | ||||||||
Health insurer fee revenue | 47,948 | 18,696 | ||||||||
Investment income | 3,015 | 1,629 | ||||||||
Other revenue | 2,303 | 3,258 | ||||||||
Total revenue | 3,171,123 | 2,069,243 | ||||||||
Operating expenses: | ||||||||||
Medical care costs | 2,635,784 | 1,721,658 | ||||||||
Cost of service revenue | 35,902 | 40,657 | ||||||||
General and administrative expenses | 256,090 | 188,087 | ||||||||
Premium tax expenses | 95,347 | 51,693 | ||||||||
Health insurer fee expenses | 40,778 | 22,190 | ||||||||
Depreciation and amortization | 24,992 | 20,691 | ||||||||
Total operating expenses | 3,088,893 | 2,044,976 | ||||||||
Operating income | 82,230 | 24,267 | ||||||||
Other expenses, net: | ||||||||||
Interest expense | 14,876 | 13,822 | ||||||||
Other income, net | (10 | ) | (44 | ) | ||||||
Total other expenses, net | 14,866 | 13,778 | ||||||||
Income from continuing operations before income tax expense | 67,364 | 10,489 | ||||||||
Income tax expense | 39,223 | 5,655 | ||||||||
Income from continuing operations | 28,141 | 4,834 | ||||||||
Income (loss) from discontinued operations, net of tax | 12 | (336 | ) | |||||||
Net income | $ | 28,153 | $ | 4,498 | ||||||
Diluted net income (loss) per share: | ||||||||||
Income from continuing operations | $ | 0.56 | $ | 0.10 | ||||||
Loss from discontinued operations | — | (0.01 | ) | |||||||
Diluted net income per share | $ | 0.56 | $ | 0.09 | ||||||
Diluted weighted average shares outstanding | 50,071 | 47,520 | ||||||||
Operating Statistics, Continuing Operations: | ||||||||||
Medical care ratio (1) | 88.7 | % | 88.7 | % | ||||||
Service revenue ratio (2) | 69.2 | % | 75.8 | % | ||||||
General and administrative expense ratio (3) | 8.1 | % | 9.1 | % | ||||||
Premium tax ratio (1) | 3.1 | % | 2.6 | % | ||||||
Effective tax rate | 58.2 | % | 53.9 | % | ||||||
Net income, continuing operations (3) | 0.9 | % | 0.2 | % | ||||||
____________ | ||||||||||
(1) Medical care ratio represents medical care costs as a percentage of premium revenue; premium tax ratio represents premium tax expenses as a percentage of premium revenue plus premium tax revenue. Medical care costs include costs incurred for providing long term services and supports (LTSS). |
||||||||||
(2) Service revenue ratio represents cost of service revenue as a percentage of service revenue. |
||||||||||
(3) Computed as a percentage of total revenue. |
||||||||||
MOLINA HEALTHCARE, INC. UNAUDITED CONSOLIDATED BALANCE SHEETS |
||||||||||
March 31, |
December 31, |
|||||||||
(Unaudited) | ||||||||||
(Amounts in thousands, |
||||||||||
ASSETS | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | $ | 1,870,024 | $ | 1,539,063 | ||||||
Investments | 1,203,866 | 1,019,462 | ||||||||
Receivables | 491,430 | 596,456 | ||||||||
Deferred income taxes | 42,631 | 39,532 | ||||||||
Prepaid expenses and other current assets | 193,498 | 50,884 | ||||||||
Derivative asset | 474,121 | — | ||||||||
Total current assets | 4,275,570 | 3,245,397 | ||||||||
Property, equipment, and capitalized software, net | 344,727 | 340,778 | ||||||||
Deferred contract costs | 57,314 | 53,675 | ||||||||
Intangible assets, net | 84,702 | 89,273 | ||||||||
Goodwill | 272,046 | 271,964 | ||||||||
Restricted investments | 101,366 | 102,479 | ||||||||
Derivative asset | — | 329,323 | ||||||||
Other assets | 34,064 | 44,326 | ||||||||
$ | 5,169,789 | $ | 4,477,215 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||
Current liabilities: | ||||||||||
Medical claims and benefits payable | $ | 1,448,132 | $ | 1,200,522 | ||||||
Amounts due government agencies | 622,158 | 527,193 | ||||||||
Accounts payable and accrued liabilities | 427,644 | 241,654 | ||||||||
Deferred revenue | 169,811 | 196,076 | ||||||||
Income taxes payable | 10,836 | 8,987 | ||||||||
Current portion of long-term debt | 440,632 | 341 | ||||||||
Derivative liability | 473,983 | — | ||||||||
Total current liabilities | 3,593,196 | 2,174,773 | ||||||||
Convertible senior notes | 270,836 | 704,097 | ||||||||
Lease financing obligations | 161,013 | 160,710 | ||||||||
Lease financing obligations - related party | 40,135 | 40,241 | ||||||||
Deferred income taxes | 29,267 | 24,271 | ||||||||
Derivative liability | — | 329,194 | ||||||||
Other long-term liabilities | 33,349 | 33,487 | ||||||||
Total liabilities | 4,127,796 | 3,466,773 | ||||||||
Stockholders’ equity: | ||||||||||
Common stock, $0.001 par value; 150,000 shares authorized; outstanding: 49,908 shares at March 31, 2015 and 49,727 shares at December 31, 2014 | 50 | 50 | ||||||||
Preferred stock, $0.001 par value; 20,000 shares authorized, no shares issued and outstanding | — | — | ||||||||
Additional paid-in capital | 398,141 | 396,059 | ||||||||
Accumulated other comprehensive income (loss) | 297 | (1,019 | ) | |||||||
Retained earnings | 643,505 | 615,352 | ||||||||
Total stockholders’ equity | 1,041,993 | 1,010,442 | ||||||||
$ | 5,169,789 | $ | 4,477,215 |
MOLINA HEALTHCARE, INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS, CONTINUING AND DISCONTINUED OPERATIONS |
||||||||||
Three Months Ended March 31, | ||||||||||
2015 | 2014 | |||||||||
(Amounts in thousands) | ||||||||||
Operating activities: | ||||||||||
Net income | $ | 28,153 | $ | 4,498 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
Depreciation and amortization | 32,574 | 32,994 | ||||||||
Deferred income taxes | 1,097 | (670 | ) | |||||||
Share-based compensation | 5,675 | 5,596 | ||||||||
Amortization of convertible senior notes and lease financing obligations | 7,290 | 6,674 | ||||||||
Other, net | 3,564 | (1,548 | ) | |||||||
Changes in operating assets and liabilities: | ||||||||||
Receivables | 105,026 | (39,297 | ) | |||||||
Prepaid expenses and other current assets | (137,278 | ) | (78,023 | ) | ||||||
Medical claims and benefits payable | 247,610 | 149,754 | ||||||||
Amounts due government agencies | 94,965 | 43,265 | ||||||||
Accounts payable and accrued liabilities | 189,373 | 58,952 | ||||||||
Deferred revenue | (26,265 | ) | 24,060 | |||||||
Income taxes | 1,849 | 4,642 | ||||||||
Net cash provided by operating activities | 553,633 | 210,897 | ||||||||
Investing activities: | ||||||||||
Purchases of investments | (438,591 | ) | (142,145 | ) | ||||||
Proceeds from sales and maturities of investments | 255,609 | 147,370 | ||||||||
Purchases of property, equipment, and capitalized software | (24,974 | ) | (17,788 | ) | ||||||
Increase in restricted investments | (4,612 | ) | (14,381 | ) | ||||||
Net cash paid in business combinations | (8,006 | ) | — | |||||||
Other, net | (7,216 | ) | (547 | ) | ||||||
Net cash used in investing activities | (227,790 | ) | (27,491 | ) | ||||||
Financing activities: | ||||||||||
Contingent consideration liabilities settled | — | (38,119 | ) | |||||||
Proceeds from employee stock plans | 1,089 | 1,330 | ||||||||
Other, net | 4,029 | 857 | ||||||||
Net cash provided by (used in) financing activities | 5,118 | (35,932 | ) | |||||||
Net increase in cash and cash equivalents | 330,961 | 147,474 | ||||||||
Cash and cash equivalents at beginning of period | 1,539,063 | 935,895 | ||||||||
Cash and cash equivalents at end of period | $ | 1,870,024 | $ | 1,083,369 | ||||||
UNAUDITED NON-GAAP FINANCIAL
MEASURES
The Company uses two non-GAAP financial measures as supplemental metrics in evaluating its financial performance, making financing and business decisions, and forecasting and planning for future periods. For these reasons, management believes such measures are useful supplemental measures to investors in comparing the Company's performance to the performance of other public companies in the health care industry. These non-GAAP financial measures should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.
The first of these non-GAAP measures is earnings before interest, taxes, depreciation and amortization (EBITDA). The following table reconciles net income, which the Company believes to be the most comparable GAAP measure, to EBITDA.
Three Months Ended March 31, |
|||||||||
2015 | 2014 | ||||||||
(Amounts in thousands) | |||||||||
Net income | $ | 28,153 | $ | 4,498 | |||||
Adjustments: | |||||||||
Depreciation, and amortization of intangible assets and capitalized software | 29,110 | 25,914 | |||||||
Interest expense | 14,876 | 13,822 | |||||||
Income tax expense | 39,240 | 5,237 | |||||||
EBITDA | $ | 111,379 | $ | 49,471 | |||||
The second of these non-GAAP measures is adjusted net income, continuing operations (including adjusted net income per diluted share). Effective for the first quarter of 2015, the Company has revised its calculation of adjusted net income, continuing operations. The Company no longer subtracts "depreciation, and amortization of capitalized software" and "share-based compensation" from net income, continuing operations to arrive at adjusted net income, continuing operations. The Company has made this change to better reflect the way in which it evaluates its financial performance, makes financing and business decisions, and forecasts and plans for future periods. All periods presented below conform to this presentation.
The following tables reconcile net income from continuing operations, which the Company believes to be the most comparable GAAP measure, to adjusted net income, continuing operations.
Three Months Ended March 31, | |||||||||||||||||||
2015 | 2014 | ||||||||||||||||||
(In thousands, except per diluted share amounts) | |||||||||||||||||||
Net income, continuing operations | $ | 28,141 | $ | 0.56 | $ | 4,834 | $ | 0.10 | |||||||||||
Adjustments, net of tax: | |||||||||||||||||||
Amortization of convertible senior notes and lease financing obligations | 4,593 | 0.09 | 4,205 | 0.10 | |||||||||||||||
Amortization of intangible assets | 2,877 | 0.06 | 3,329 | 0.07 | |||||||||||||||
Adjusted net income, continuing operations | $ | 35,611 | $ | 0.71 | $ | 12,368 | $ | 0.27 | |||||||||||
MOLINA HEALTHCARE, INC. UNAUDITED HEALTH PLANS SEGMENT MEMBERSHIP, CONTINUING OPERATIONS |
|||||||||||
March 31, |
December 31, |
March 31, |
|||||||||
Ending Membership by Health Plan: | |||||||||||
California | 574,000 | 531,000 | 418,000 | ||||||||
Florida | 352,000 | 164,000 | 91,000 | ||||||||
Illinois | 102,000 | 100,000 | 5,000 | ||||||||
Michigan | 256,000 | 242,000 | 218,000 | ||||||||
New Mexico | 222,000 | 212,000 | 183,000 | ||||||||
Ohio | 350,000 | 347,000 | 260,000 | ||||||||
South Carolina | 111,000 | 118,000 | 126,000 | ||||||||
Texas | 268,000 | 245,000 | 246,000 | ||||||||
Utah | 90,000 | 83,000 | 80,000 | ||||||||
Washington | 533,000 | 497,000 | 434,000 | ||||||||
Wisconsin | 107,000 | 84,000 | 90,000 | ||||||||
2,965,000 | 2,623,000 | 2,151,000 | |||||||||
Ending Membership by Program: | |||||||||||
Temporary Assistance for Needy Families (TANF), CHIP(1) | 1,825,000 | 1,809,000 | 1,659,000 | ||||||||
Medicaid Expansion(2) | 437,000 | 385,000 | 133,000 | ||||||||
Aged, Blind or Disabled (ABD) | 358,000 | 347,000 | 310,000 | ||||||||
Marketplace(2) | 266,000 | 15,000 | 8,000 | ||||||||
Medicare Special Needs Plans | 45,000 | 49,000 | 41,000 | ||||||||
Medicare-Medicaid Plan (MMP) - Integrated(3) | 34,000 | 18,000 | — | ||||||||
2,965,000 | 2,623,000 | 2,151,000 | |||||||||
_______________________ | |||||||||||
(1) CHIP stands for Children's Health Insurance Program. |
|||||||||||
(2) Medicaid Expansion membership phased in, and Marketplace became available for consumers to access coverage, beginning January 1, 2014. |
|||||||||||
(3) MMP members who receive both Medicaid and Medicare coverage from the Company. The Company began serving members under this program in the second quarter of 2014. |
|||||||||||
MOLINA HEALTHCARE, INC. UNAUDITED SELECTED HEALTH PLANS SEGMENT FINANCIAL DATA, CONTINUING OPERATIONS (In thousands, except percentages and per-member per-month amounts) |
|||||||||||||||||||||||||||||||||
Three Months Ended March 31, 2015 | |||||||||||||||||||||||||||||||||
Member Months(1) |
Premium Revenue | Medical Care Costs | MCR(2) |
Medical |
|||||||||||||||||||||||||||||
Total | PMPM | Total | PMPM | ||||||||||||||||||||||||||||||
California | 1,673 | $ | 510,544 | $ | 305.10 | $ | 452,435 | $ | 270.37 | 88.6 | % | $ | 58,109 | ||||||||||||||||||||
Florida | 897 | 310,971 | 346.46 | 281,389 | 313.51 | 90.5 | 29,582 | ||||||||||||||||||||||||||
Illinois | 305 | 104,145 | 341.86 | 89,437 | 293.58 | 85.9 | 14,708 | ||||||||||||||||||||||||||
Michigan | 756 | 219,525 | 290.29 | 184,763 | 244.32 | 84.2 | 34,762 | ||||||||||||||||||||||||||
New Mexico | 684 | 313,656 | 458.75 | 291,826 | 426.82 | 93.0 | 21,830 | ||||||||||||||||||||||||||
Ohio | 1,055 | 515,087 | 488.26 | 413,074 | 391.56 | 80.2 | 102,013 | ||||||||||||||||||||||||||
South Carolina | 343 | 91,326 | 266.42 | 74,269 | 216.67 | 81.3 | 17,057 | ||||||||||||||||||||||||||
Texas | 775 | 381,785 | 492.38 | 351,478 | 453.30 | 92.1 | 30,307 | ||||||||||||||||||||||||||
Utah | 266 | 77,142 | 290.27 | 74,144 | 278.99 | 96.1 | 2,998 | ||||||||||||||||||||||||||
Washington | 1,563 | 376,350 | 240.83 | 352,374 | 225.49 | 93.6 | 23,976 | ||||||||||||||||||||||||||
Wisconsin | 302 | 60,342 | 199.61 | 48,709 | 161.13 | 80.7 | 11,633 | ||||||||||||||||||||||||||
Other(3) | — | 9,779 | — | 21,886 | — | — | (12,107 | ) | |||||||||||||||||||||||||
8,619 | $ | 2,970,652 | $ | 344.65 | $ | 2,635,784 | $ | 305.80 | 88.7 | % | $ | 334,868 | |||||||||||||||||||||
Three Months Ended March 31, 2014 | |||||||||||||||||||||||||||||||||
Member Months(1) |
Premium Revenue | Medical Care Costs | MCR(2) |
Medical |
|||||||||||||||||||||||||||||
Total | PMPM | Total | PMPM | ||||||||||||||||||||||||||||||
California | 1,254 | $ | 277,642 | $ | 221.42 | $ | 237,344 | $ | 189.28 | 85.5 | % | $ | 40,298 | ||||||||||||||||||||
Florida | 270 | 105,166 | 389.67 | 93,461 | 346.30 | 88.9 | 11,705 | ||||||||||||||||||||||||||
Illinois | 14 | 15,171 | 1,078.41 | 14,494 | 1,030.28 | 95.5 | 677 | ||||||||||||||||||||||||||
Michigan | 648 | 173,496 | 267.58 | 135,320 | 208.70 | 78.0 | 38,176 | ||||||||||||||||||||||||||
New Mexico | 549 | 225,068 | 410.00 | 196,409 | 357.79 | 87.3 | 28,659 | ||||||||||||||||||||||||||
Ohio | 772 | 278,295 | 360.62 | 237,328 | 307.53 | 85.3 | 40,967 | ||||||||||||||||||||||||||
South Carolina | 394 | 96,020 | 243.41 | 90,262 | 228.82 | 94.0 | 5,758 | ||||||||||||||||||||||||||
Texas | 749 | 320,096 | 427.27 | 292,958 | 391.05 | 91.5 | 27,138 | ||||||||||||||||||||||||||
Utah | 246 | 78,654 | 319.96 | 67,200 | 273.37 | 85.4 | 11,454 | ||||||||||||||||||||||||||
Washington | 1,276 | 323,461 | 253.48 | 298,107 | 233.61 | 92.2 | 25,354 | ||||||||||||||||||||||||||
Wisconsin | 274 | 38,528 | 140.67 | 28,809 | 105.19 | 74.8 | 9,719 | ||||||||||||||||||||||||||
Other(3) | — | 8,740 | — | 29,966 | — | — | (21,226 | ) | |||||||||||||||||||||||||
6,446 | $ | 1,940,337 | $ | 301.00 | $ | 1,721,658 | $ | 267.08 | 88.7 | % | $ | 218,679 | |||||||||||||||||||||
____________ | |||||||||||||||||||||||||||||||||
(1) A member month is defined as the aggregate of each month's ending membership for the period presented. |
|||||||||||||||||||||||||||||||||
(2) The MCR represents medical costs as a percentage of premium revenue. |
|||||||||||||||||||||||||||||||||
(3) "Other" medical care costs include primarily medically related administrative costs at the parent company, and direct delivery costs. |
|||||||||||||||||||||||||||||||||
MOLINA HEALTHCARE, INC. UNAUDITED SELECTED HEALTH PLANS SEGMENT FINANCIAL DATA, CONTINUING OPERATIONS (In thousands, except percentages and per-member per-month amounts) |
||||||||||||||||||||||||||||||||
Three Months Ended March 31, 2015(1) |
||||||||||||||||||||||||||||||||
Member Months(2) |
Premium Revenue | Medical Care Costs | MCR(3) |
Medical |
||||||||||||||||||||||||||||
Total | PMPM | Total | PMPM | |||||||||||||||||||||||||||||
TANF and CHIP | 5,479 | $ | 972,039 | $ | 177.40 | $ | 896,826 | $ | 163.67 | 92.3 | % | $ | 75,213 | |||||||||||||||||||
Medicaid Expansion | 1,274 | 506,896 | 397.99 | 393,031 | 308.59 | 77.5 | 113,865 | |||||||||||||||||||||||||
ABD | 1,051 | 940,268 | 894.70 | 862,520 | 820.72 | 91.7 | 77,748 | |||||||||||||||||||||||||
Marketplace | 582 | 193,511 | 332.52 | 156,314 | 268.60 | 80.8 | 37,197 | |||||||||||||||||||||||||
Medicare | 131 | 133,335 | 1,013.66 | 128,497 | 977.09 | 96.4 | 4,838 | |||||||||||||||||||||||||
MMP | 102 | 224,603 | 2,206.17 | 198,596 | 1,950.71 | 88.4 | 26,007 | |||||||||||||||||||||||||
8,619 | $ | 2,970,652 | $ | 344.65 | $ | 2,635,784 | $ | 305.80 | 88.7 | % | $ | 334,868 | ||||||||||||||||||||
_______________________ | ||||||||||||||||||||||||||||||||
(1) Three months ended March 31, 2014 data not presented due to lack of comparability. |
||||||||||||||||||||||||||||||||
(2) A member month is defined as the aggregate of each month's ending membership for the period presented. |
||||||||||||||||||||||||||||||||
(3) The MCR represents medical costs as a percentage of premium revenue |
The following tables provide the details of the Company’s medical care costs from continuing operations for the periods indicated: |
||||||||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||||||
Amount | PMPM |
% of Total |
Amount | PMPM |
% of Total |
|||||||||||||||||||||||
Fee for service | $ | 1,948,305 | $ | 226.04 | 73.9 | % | $ | 1,181,061 | $ | 183.21 | 68.6 | % | ||||||||||||||||
Pharmacy | 351,198 | 40.75 | 13.3 | 286,628 | 44.46 | 16.7 | ||||||||||||||||||||||
Capitation | 216,325 | 25.10 | 8.2 | 169,439 | 26.28 | 9.8 | ||||||||||||||||||||||
Direct delivery | 26,771 | 3.11 | 1.0 | 22,021 | 3.42 | 1.3 | ||||||||||||||||||||||
Other | 93,185 | 10.80 | 3.6 | 62,509 | 9.71 | 3.6 | ||||||||||||||||||||||
$ | 2,635,784 | $ | 305.80 | 100.0 | % | $ | 1,721,658 | $ | 267.08 | 100.0 | % |
The following table provides the details of the Company's medical claims and benefits payable as of the dates indicated: |
|||||||||
March 31, |
December 31, |
||||||||
Fee-for-service claims incurred but not paid (IBNP) | $ | 1,089,903 | $ | 870,429 | |||||
Pharmacy payable | 84,180 | 71,412 | |||||||
Capitation payable | 47,171 | 28,150 | |||||||
Other (1) | 226,878 | 230,531 | |||||||
$ | 1,448,132 | $ | 1,200,522 | ||||||
______________________ | |||||||||
(1) “Other” medical claims and benefits payable include amounts payable to certain providers for which the Company acts as an intermediary on behalf of various state agencies without assuming financial risk. Such receipts and payments do not impact the Company’s unaudited consolidated statements of income. As of March 31, 2015 and December 31, 2014, the Company had recorded non-risk provider payables of approximately $105.4 million and $119.3 million, respectively. |
|||||||||
UNAUDITED CHANGE IN MEDICAL
CLAIMS AND BENEFITS PAYABLE
(Dollars in thousands, except
per-member amounts)
The Company’s claims liability includes an allowance for adverse claims deviation based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior period” represent the amount by which the Company’s original estimate of claims and benefits payable at the beginning of the period were more than the actual amount of the liability based on information (principally the payment of claims) developed since that liability was first reported. The following table presents the components of the change in medical claims and benefits payable from continuing and discontinued operations combined for the periods indicated:
Three Months Ended March 31, |
Year Ended |
||||||||||||||
2015 | 2014 | ||||||||||||||
Medical claims and benefits payable, beginning balance | $ | 1,200,522 | $ | 669,787 | $ | 669,787 | |||||||||
Components of medical care costs related to: | |||||||||||||||
Current period | 2,771,588 | 1,773,332 | 8,122,885 | ||||||||||||
Prior period (1) |
(135,833 | ) | (50,904 | ) | (45,979 | ) | |||||||||
Total medical care costs | 2,635,755 | 1,722,428 | 8,076,906 | ||||||||||||
Change in non-risk provider payables | (13,914 | ) | (28,560 | ) | (31,973 | ) | |||||||||
Payments for medical care costs related to: | |||||||||||||||
Current period | 1,647,981 | 1,172,672 | 7,064,427 | ||||||||||||
Prior period | 726,250 | 371,442 | 449,771 | ||||||||||||
Total paid | 2,374,231 | 1,544,114 | 7,514,198 | ||||||||||||
Medical claims and benefits payable, ending balance | $ | 1,448,132 | $ | 819,541 | $ | 1,200,522 | |||||||||
Benefit from prior period as a percentage of: | |||||||||||||||
Balance at beginning of period | 11.3 | % | 7.6 | % | 6.9 | % | |||||||||
Premium revenue, trailing twelve months | 1.4 | % | 0.8 | % | 0.5 | % | |||||||||
Medical care costs, trailing twelve months | 1.5 | % | 0.9 | % | 0.6 | % | |||||||||
Fee-For-Service Claims Data: | |||||||||||||||
Days in claims payable, fee for service | 51 | 46 | 49 | ||||||||||||
Number of members at end of year | 2,965,000 | 2,151,000 | 2,623,000 | ||||||||||||
Number of claims in inventory at end of year | 319,300 | 287,300 | 307,700 | ||||||||||||
Billed charges of claims in inventory at end of year |
$ | 848,200 | $ | 517,300 | $ | 718,500 | |||||||||
Claims in inventory per member at end of year | 0.11 | 0.13 | 0.12 | ||||||||||||
Billed charges of claims in inventory per member at end of year |
$ | 286.07 | $ | 240.49 | $ | 273.92 | |||||||||
Number of claims received during the year | 8,635,500 | 5,986,000 | 27,597,000 | ||||||||||||
Billed charges of claims received during the year | $ | 9,891,800 | $ | 6,354,000 | $ | 30,315,600 | |||||||||
_________________ | |||||||||||||||
(1) The benefit from prior period development of medical claims and benefits payable for the three months ended March 31, 2015, included approximately $25 million relating to programs that contain medical cost floor or corridor provisions. Accordingly, premium revenue for the three months ended March 31, 2015, was reduced by the same amount. |
|||||||||||||||
MOLINA HEALTHCARE, INC. HEALTH INSURER FEE DETAILS BY HEALTH PLAN (In thousands) |
||||||||||||||
HIF Reimbursement Revenue, Gross(1) |
||||||||||||||
Three Months Ended |
Year Ended |
|||||||||||||
Recognized |
Necessary for |
Necessary for |
||||||||||||
2015 HIF: | ||||||||||||||
California | $ | — | $ | 7,724 | $ | 30,898 | ||||||||
Florida | 2,027 | 2,027 | 8,108 | |||||||||||
Illinois | 965 | 965 | 3,861 | |||||||||||
Michigan | — | 6,998 | 27,993 | |||||||||||
New Mexico | 7,539 | 7,539 | 30,157 | |||||||||||
Ohio | 11,936 | 11,936 | 47,743 | |||||||||||
South Carolina | 3,053 | 3,053 | 12,214 | |||||||||||
Texas | 5,839 | 5,839 | 23,357 | |||||||||||
Utah | — | 1,453 | 5,813 | |||||||||||
Washington | 10,951 | 10,951 | 43,802 | |||||||||||
Wisconsin | 1,126 | 1,126 | 4,505 | |||||||||||
Subtotal, Medicaid | 43,436 | 59,611 | 238,451 | |||||||||||
Marketplace | 398 | 398 | 1,586 | |||||||||||
Medicare | 5,702 | 5,702 | 22,801 | |||||||||||
$ | 49,536 | $ | 65,711 | $ | 262,838 | |||||||||
Recognized in: | ||||||||||||||
Health insurer fee revenue | $ | 47,948 | ||||||||||||
Premium tax revenue | 1,588 | |||||||||||||
$ | 49,536 | |||||||||||||
_____________ | ||||||||||||||
(1) Amounts in the table include the Company's estimate of the full economic impact of the excise tax including premium tax and the income tax effect. |
||||||||||||||
|
||||||||||||||
Source:
Molina Healthcare, Inc.
Investor Relations:
Juan José
Orellana, 562-435-3666, ext. 111143